Cartilage tissue engineering approaches applicable in orthopaedic surgery: The past, the present, and the future

Journal of Stem Cells

Volumn 7, Issue 2, 2012, Pages 97-104

  Khan, Wasim S ^a   Hardingham, Timothy E ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROCYTE IMPLANT; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; COLLAGEN TYPE 6; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ARTHRODESIS; ARTICLE; ARTICULAR CARTILAGE; AUTOTRANSPLANTATION; CARTILAGE TRANSPLANTATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CELL RENEWAL; CHONDROCYTE IMPLANTATION; CHONDROGENESIS; CHONDROPATHY; CLINICAL PRACTICE; CROSS LINKING; DAILY LIFE ACTIVITY; DEVELOPED COUNTRY; DISEASE COURSE; EMBRYOLOGY; EXTRACELLULAR MATRIX; FEMORAL CONDYLAR CARTILAGE DEFECT; GENE EXPRESSION; HEALTH CARE COST; HUMAN; HYALINE CARTILAGE; JOINT BIOPSY; KNEE ARTHROPLASTY; MESENCHYMAL STEM CELL TRANSPLANTATION; OCCUPATIONAL THERAPY; ORTHOPEDIC SURGERY; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; PATHOPHYSIOLOGY; PERIOSTEUM; PHYSIOTHERAPY; PRODUCTIVITY; PROTEIN EXPRESSION; QUALITY OF LIFE; SOCIOECONOMICS; TIBIA OSTEOTOMY; TISSUE ENGINEERING; TISSUE GROWTH;

CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; ORTHOPEDICS; TISSUE ENGINEERING;

EID: 84866177758     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Bentley G, Minas T (2000). Treating joint damage in young people. BMJ. 320: 1585-8.
2. Bentley G, Biant LC, Carrington RW, Akmal M, Goldberg A, Williams AM, Skinner JA, Pringle J (2003). A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicoplasty for osteochondral defects in the knee. J. Bone Joint Surg. 85B: 223-30.
3. Benya PD, Shaffer JD (1982). Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell; 30: 215-24.
4. Brittberg M, Lindahl A, Nilsson C, Isaksson O, Patterson L (1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331: 889-95.
5. Brittberg M, Tallheden T, Sjogren-Jansson B, Lindahl A, Peterson L (2001). Autologous chondrocytes used for articular cartilage repair: an update. Clin. Orthop. 391: S337-48.
6. Brittberg M, Peterson L, Sjogren-Jansson E, Tallheden T, Lindahl A (2003). Articular cartilage engineering with autologous chondrocyte transplantation. J. Bone Joint Surg. 85A: 109-15.
7. Buckwalter JA (2002). Articular cartilage injuries. Clin. Orthop. Relat Res. 402: 21-37.
8. Cancedda R, Dozin B, Giannoni P, Quarto R (2003). Tissue engineering and cell therapy of cartilage and bone. Matrix Biol. 22: 81-91.
9. Chia SL, Sawaji Y, Burleigh A, McLean C, Inglis J, Saklatvala J, Vincent T (2009). Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60: 2019-27.
10. Clar C, Cummins E, McIntyre L, Thomas S, Lamb J, Bain L, Jobanputra P, Waugh N (2005). Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess. 9: 1-82.
11. Dennis JE, Caplan AI (2000). Bone marrow mesenchymal stem cells. Stem cell handbook by Stewart Sell. Humana Press.
12. Dennis JE, Carbillet JP, Caplan AI, Charbord P (2002). The STRO-1+ marrow cell population is multipotential. Cells Tissues Organs. 170: 73-82.
13. Dragoo JL, Samimi B, Zhu M, Hame SL, Thomas BJ, Lieberman JR, Hedrick MH, Benhaim P (2003). Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J. Bone Joint Surg. 85B: 740-7.
14. Duri ZA, Aichroth PM, Dowd G (1996). The fat pad: Clinical observations. Am. J. Knee Surg. 9: 55-66.
15. Eyre DR (1991). The collagens of articular cartilage. Semin Arthritis Rheum. 21: 2-11.
16. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H (2005). Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J. Biol Chem. 280: 8343-50.
17. Hardingham TE, Fosang AJ (1992). Proteoglycans: many forms and many functions. FASEB J. 6: 861-70.
18. Hardingham TE (1998). Pathophysiology of musculoskeletal disease. In Oxford Textbook of Rheumatology. Maddison PJ, Isenberg DA, Woo P, Glass DN Eds. Second edition Oxford Medical Publications: 1-10.
19. Hardingham T, Tew S, Murdoch A (2002). Tissue engineering: chondrocytes and cartilage. Arthritis Res. 4: S63-8.
20. Hiraki Y, Shukunami C, Iyama K, Mizuta H (2001). Differentiation of chondrogenic precursor cells during the regeneration of articular cartilage. Osteoarthritis Cartilage. 9: S102-8.
21. Homicz MR, Schumacher BL, Sah RL, Watson D (2002). Effects of serial expansion of septal chondrocytes on tissue-engineered neocartilage composition. Otolaryngol Head Neck Surg. 127: 398-408.
22. Huang JI, Kazmi N, Durbhakula MM, Hering TM, Yoo JU, Johnstone B (2005). Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient matched comparison. J. Orthop Res. 23: 1383-9.
23. Hunziker EB (2001). Articular cartilage repair: basic science and clinical progress; a review of the current status and prospects. Osteoarthritis Cartilage. 10: 432-63.
24. Indrawattana N, Chen G, Tadokoro M, Shann LH, Ohgushi H, Tateishi T, Tanaka J, Bunyaratvej A (2004). Growth factor combination for chondrogenic induction from human mesenchymal stem cell. Biochem Biophys Res Commun. 320: 914-9.
25. Jaiswal PK, Wong K, Khan WS (2010). Current cell based strategies for knee cartilage injuries. J. Stem Cells. 5(4):177-85.
26. Jaiswal PK, Wong K, Khan WS (2011). Operative Treatment of Knee Cartilage Injuries: A Review of the Current Literature on Non-Cell-Based and Cell-Based Therapies. Br.J. Med. Med. Res. 1(4): 516-537.
27. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238: 265-72.
28. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, McGonagle D (2004). Enumeration and phenotypic characterisation of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum. 50: 817-27.
29. Karsenty G, Wagner EF (2002). Reaching a genetic and molecular understanding of skeletal development. Dev Cell. 2: 389-406.
30. Kato Y, Gospodarowicz D (1985). Sulfated proteoglycan synthesis by confluent cultures of rabbit costal chondrocytes grown in the presence of fibroblast growth factor. J. Cell Biol. 100: 477-85.
31. Khan WS, Adesida AB, Hardingham TE (2007). Hypoxic conditions increase hypoxia-inducible transcription factor 2alpha and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Res Ther. 9: R55.
32. Khan WS, Tew SR, Adesida AB, Hardingham TE (2008). Human infrapatellar fat pad-derived stem cells express the pericyte marker 3G5 and show enhanced chondrogenesis after expansion in fibroblast growth factor-2. Arthritis Res Ther. 10: R74.
33. Khan WS, Johnson DS, Hardingham DS (2010). The Potential Use of Stem Cells for Knee Articular Cartilage Repair. Knee. 17(6): 369-74.
34. Kuroda R, Isada K, Matsumoto T, Akisue T, Fujioka H, Mizuno K, Ohgushi H, Wakitani S, Kurosaka M (2007). Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage. 15: 226-31.
35. Lee CR, Grodzinsky AJ, Hsu HP, Martin SD, Spector M (2000). Effects of harvest and selected cartilage repair procedures on the physical and biochemical properties of articular cartilage in the canine knee. J. Orthop. Res. 18: 790-9.
36. Li Y, Tew SR, Russel AM, Gonzalez KR, Hardingham TE, Hawkins RE (2004). Transduction of passaged human articular chondrocytes with adenoviral, retroviral, and lentiviral vectors and the effects of enhanced expression of SOX9. Tissue Eng. 10: 575-84.
37. Loty S, Forest N, boulekbache H, Sautier JM (1995). Cytochalasin D induces changes in cell shape and promotes in vitro chondrogenesis: a morphological study. Biol. Cell. 83: 149-61.
38. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF (1998). Chondrogenic differentiation of cultured marrow mesenchymal stem cells from marrow. Tissue Eng. 4: 415-28.
39. Magne D, Vinatier C, Julien M, Weiss P, Guicheux J (2005a). Mesenchymal stem cell therapy to rebuild cartilage. Trends Mol. Med. 11: 519-26.
40. Magne D, Julien M, Vinatier C, Merhi-Soussi F, Weiss P, Guicheux J (2005b). Cartilage formation in growth plate and arteries: from physiology to pathology. Bioessays; 27: 708-16.
41. Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H, Sekiya I (2006). Higher chondrogenic potential of fibrous synovium-and adipose synovium-derived cells compared with subcutaneous fat-derived cells. Arthritis Rheum. 54: 843-53.
42. Newman A (1998). Articular cartilage repair. Am. J. Sports Med. 26: 309-24.
43. Newton Ede MP, Khan WS (2010). The Challenges of Cartilage Repair and the Potential of Stem Cell Applications. J. Stem Cells. 5(4): 167-175.
44. ODriscoll SW (1998). The healing and regeneration of articular cartilage. J. Bone Joint Surg. Am. 80: 1795-812.
45. Oragui E, Nannaparaju M, Khan WS (2011). The role of bioreactors in tissue engineering for musculoskeletal applications. Open Orthop J. 5(2): 267-70.
46. Parsons IM, Sonnabend DH (2004). What is the role of joint replacement surgery? Best Pract Res. Clin. Rheumatol. 18: 557-72.
47. Perera JR, Jaiswal PK, Khan WS (2012). The potential therapeutic use of stem cells in cartilage repair. Curr. Stem Cell Res. Ther. 7(2): 149-56.
48. Peterson L, Minas T, Brittberg M, Lindahl A (2003). Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J. Bone Joint Surg. 85A: 17-24.
49. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999). Multilineage potential of adult human mesenchymal stem cells. Science. 284: 143-7.
50. Pittenger MF, Mbalaviele G, Black M, Mosca JD, Marshak DR (2001). Mesenchymal stem cells. In: Koller MR, Palsson BO, Masters JRW Eds. Primary mesenchymal cells. Dordrecht; Boston: Kluwer Academic Publishers: 189-207.
51. Pittinger MF, Martin BJ (2004). Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95: 9-20.
52. Poole AR (1995). Imbalance of anabolism and catabolism of cartilage matrix componenets in osteoarthritis. In: Kuettner KE, Goldberg B Eds. Osteoarthritic disorders. Rosemont: AAOS: 247-60.
53. Punwar S, Khan WS (2011). Mesenchymal stem cells and articular cartilage repair: Clinical studies and future direction. Open Orthop J. 5(2): 296-301.
54. Raghunath J, Salacinski HJ, Sales KM, Butler PE, Seifalian M (2005). Advancing cartilage tissue engineering: the application of stem cell technology. Curr. Opin. Biotech. 16: 503-9.
55. Risbud MV, Sittinger M (2002). Tissue engineering: advances in in vitro cartilage generation. Trends Biotech. 20: 351-6.
56. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T (2005). Comparison of human stem cells derived from various mesenchymal tissues-Superiority of synovium as a cell source. Arthritis Rheum. 52: 2521-9.
57. Scharstuhl A, Schewe B, Benz K, Gaissmaier C, Bühring HJ, Stoop R (2007). Chondrogenic potential of human adult mesenchymal stem cells is independent of age or osteoarthritis etiology. Stem Cells. 25: 3244-51.
58. Schulz RM, Bader A (2007). Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondrocytes. Eur. Biophys. J. 36: 539-68.
59. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ (2002). In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl. Acad. Sci. USA. 99: 4397-402.
60. Shapiro F, Koide S, Glimcher MJ (1993). Cell origin and differentiation in the repair of full thickness defects of articular cartilage. J. Bone Joint Surg. Am. 75: 532-53.
61. Simon L (1999). Osteoarthritis: a review. Clin. Cornerstone. 2: 26-37.
62. st edn. London: Churchill Livingstone.
63. Tew SR, Hardingham TE (2006). Regulation of SOX9 mRNA in Human Articular Chondrocytes Involving p38 MAPK Activation and mRNA Stabilization. J. Biol. Chem. 281: 39471-9.
64. Thanabalasundaram G, Arumalla N, Tailor HD, Khan WS (2012). Regulation of differentiation of mesenchymal stem cells into musculoskeletal cells. Curr. Stem Cell Res Ther. 7(2): 95-102.
65. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM (1994). Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 76: 579-92.
66. Wickham MQ, Erickson GR, Gimble JM, Vail TP, Guilak F (2003). Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin. Orthop. 412: 196-212.
67. th edn. New York: Churchill Livingstone.
68. Wollheim F (1996). Current pharmacological treatments of osteoarthritis. Drugs. 52: 27-38.
69. Wroblewski J, Edwall-Arvidsson C (1995). Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J. Bone Miner Res. 10: 735-42.